Skip to main content
Top

Drugs

Issue 11/2017

Content (10 Articles)

The Whole Price of Vancomycin: Toxicities, Troughs, and Time

  • Open Access
  • Current Opinion

Meghan N. Jeffres

A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?

  • Review Article

Wendy L. St. Peter, Lori D. Wazny, Eric Weinhandl, Katie E. Cardone, Joanna Q. Hudson

The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis

  • Open Access
  • Systematic Review

Amirhossein Sahebkar, Maria-Corina Serban, Peter Penson, Camelia Gurban, Sorin Ursoniu, Peter P. Toth, Steven R. Jones, Giuseppe Lippi, Kazuhiko Kotani, Karam Kostner, Manfredi Rizzo, Jacek Rysz, Maciej Banach

Abatacept: A Review in Rheumatoid Arthritis

  • Adis Drug Evaluation

Hannah A. Blair, Emma D. Deeks

Eftrenonacog Alfa: A Review in Haemophilia B

  • Adis Drug Evaluation

Sheridan M. Hoy

Cerliponase Alfa: First Global Approval

  • AdisInsight Report

Anthony Markham

Midostaurin: First Global Approval

  • AdisInsight Report

Esther S. Kim

Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects

  • Erratum

Shubhasree Banerjee, Ann Biehl, Massimo Gadina, Sarfaraz Hasni, Daniella M. Schwartz

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images